Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PSEN1 mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of PSEN1 mRNA | increases expression | 18648102
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of PSEN1 mRNA | affects expression | 17562736
|
D000638 |
Amiodarone |
Amiodarone results in increased expression of PSEN1 mRNA | increases expression | 19774075
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PSEN1 mRNA | affects expression | 16483693
|
C015001 |
arsenite |
arsenite results in increased expression of PSEN1 mRNA | increases expression | 18191166
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PSEN1 mRNA | decreases expression | 19150397
|
D011345 |
Fenofibrate |
Fenofibrate affects the reaction [PSEN1 protein affects the cleavage of APP protein] | affects cleavage|affects reaction | 17962197
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of PSEN1 mRNA | decreases expression | 12057914
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of PSEN1 mRNA | increases expression | 12057914
|
C406082 |
monomethylarsonous acid |
monomethylarsonous acid results in decreased expression of PSEN1 mRNA | decreases expression | 20024957
|
C484278 |
N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide |
PSEN1 gene mutant form results in decreased susceptibility to N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide | decreases response to substance | 17573346
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of PSEN1 mRNA | increases expression | 17616710
|
C030110 |
oxaliplatin |
oxaliplatin results in increased expression of PSEN1 protein | increases expression | 19147571
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of PSEN1 mRNA | increases expression | 19363144
|
D011374 |
Progesterone |
Progesterone inhibits the reaction [PSEN1 gene mutant form results in decreased metabolism of Progesterone metabolite] | decreases metabolic processing|decreases reaction | 17988898
|
D011374 |
Progesterone |
PSEN1 gene mutant form results in decreased metabolism of Progesterone metabolite | decreases metabolic processing | 17988898
|
C045950 |
propiconazole |
propiconazole results in increased expression of PSEN1 mRNA | increases expression | 19363144
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of PSEN1 mRNA | decreases expression | 18175754
|
C025462 |
sulindac sulfide |
sulindac sulfide affects the localization of PSEN1 protein | affects localization | 18359496
|
C025462 |
sulindac sulfide |
PSEN1 gene mutant form results in decreased susceptibility to sulindac sulfide | decreases response to substance | 17573346
|
C025462 |
sulindac sulfide |
PSEN1 protein affects the reaction [sulindac sulfide affects the cleavage of APP protein] | affects cleavage|affects reaction | 12805356
|
C025462 |
sulindac sulfide |
PSEN1 protein mutant form promotes the reaction [sulindac sulfide affects the cleavage of APP protein] | affects cleavage|increases reaction | 12805356
|
C025462 |
sulindac sulfide |
sulindac sulfide affects the reaction [PSEN1 protein affects the cleavage of APP protein] | affects cleavage|affects reaction | 17962197
|
C025462 |
sulindac sulfide |
sulindac sulfide results in decreased activity of PSEN1 protein | decreases activity | 17573346
|
C025462 |
sulindac sulfide |
[sulindac sulfide results in decreased activity of PSEN1 protein] which affects the cleavage of APP protein | affects cleavage|decreases activity | 17573346
|
C032910 |
triadimefon |
triadimefon results in increased expression of PSEN1 mRNA | increases expression | 19363144
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
3.38 | 6195326 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.50 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
3.97 | 18653653 11850527 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.71 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
3.91 | 17620307 |
MESH:D000544 |
Alzheimer Disease |
marker/mechanism |
|
| 17573346 17962197 16449385 17192785 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
3.07 | 18759972 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.79 | 10982225 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
3.74 | 18057881 18218290 20041841 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.85 | 18651412 19698954 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.42 | 18445737 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.96 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
3.84 | 19483382 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.28 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.19 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.47 | 17614352 15562024 16175315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.46 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
6.46 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
6.46 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
6.46 | 1701930 20007298 20935162 6705139 17173139 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
3.42 | 12391285 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.64 | 7296757 |
MESH:D002311 |
Cardiomyopathy, Dilated |
marker/mechanism |
|
| |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
2.87 | 15710769 19225199 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
5.02 | 18974383 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.54 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
15.69 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
15.69 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
15.69 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
monomethylarsonous acid |
15.69 | 19716837 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.19 | 4080065 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
3.10 | 19486331 9022650 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.69 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
triadimefon |
3.70 | 16781842 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
4.27 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
oxaliplatin |
4.27 | 16024531 16004971 16510598 |
MESH:D015179 |
Colorectal Neoplasms |
|
oxaliplatin |
2.94 | 18509181 18448328 17255274 17695437 17401013 17594712 |
MESH:D019465 |
Craniofacial Abnormalities |
|
triadimefon |
2.88 | 16875885 15834900 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.95 | 18551238 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.74 | 11298694 8156756 11906362 14531868 8970840 18759878 12868966 2524372 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.43 | 2952479 3621924 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.72 | 16285004 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.43 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
11.81 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
11.81 | 6679447 9328219 9653073 18289764 9022650 1440618 8291058 7440962 18692083 6482804 16192314 11289319 18648102 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
11.81 | 19370779 19420014 10915739 16081117 12392966 12594235 11739529 15968718 16393943 19085960 12705907 2444490 10663392 11421492 10774834 16781746 18071297 16177239 12540782 19164858 12153990 17906064 16485898 14725611 11743745 16227642 11529661 11461765 17562736 12958197 18713872 17522070 14550746 19923254 11287661 11834606 19416960 16109766 19739265 14986274 15619225 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
11.81 | 18218290 15265979 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
11.81 | 15131321 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.04 | 19426721 |
MESH:D050171 |
Dyslipidemias |
|
Fenofibrate |
4.38 | 16707586 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.94 | 1851702 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.72 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Fenofibrate |
4.05 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.70 | 16134523 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.33 | 17637181 15328337 15821434 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.04 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.82 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.86 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.48 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.19 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.96 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.19 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.19 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
7.19 | 15150132 15878914 16704527 16510608 15547733 15547721 16805852 15264214 15623463 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
7.97 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
7.97 | 18296743 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.95 | 9205823 11852909 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.96 | 6705139 |
MESH:D005355 |
Fibrosis |
|
arsenite |
4.00 | 18296743 |
MESH:D057180 |
Frontotemporal Dementia |
marker/mechanism |
|
| |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.62 | 16983495 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.97 | 7505956 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.32 | 16366002 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.45 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
20.32 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
20.32 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
propiconazole |
20.32 | 17178688 17178689 |
MESH:D006529 |
Hepatomegaly |
|
triadimefon |
20.32 | 17178688 17178689 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.86 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
oxaliplatin |
7.86 | 17418472 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
3.81 | 8137927 9751232 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.88 | 15034207 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
4.45 | 17991464 18020914 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.34 | 15869954 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
5.24 | 17237260 12878042 9205823 17255318 17963957 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.24 | 15869954 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.23 | 14714311 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.57 | 17255318 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.96 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
triadimefon |
4.90 | 15834900 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.16 | 12587719 15629191 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.17 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.17 | 6582329 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.64 | 15821434 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
3.46 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
6.74 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.74 | 21047994 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.15 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Fenofibrate |
3.02 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
3.02 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
9.34 | 12587719 19014921 11587558 19460945 16610002 19784758 12969438 16611625 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
9.34 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
propiconazole |
9.34 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
triadimefon |
9.34 | 19363144 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.18 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
14.04 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Fenofibrate |
14.04 | 18978307 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
14.04 | 19073162 15975961 21047994 8742319 19482888 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
propiconazole |
14.04 | 19028983 |
MESH:D008113 |
Liver Neoplasms |
|
triadimefon |
14.04 | 19028983 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
22.86 | 2876786 6135515 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
22.86 | 1399818 3712494 6587162 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Fenofibrate |
22.86 | 18775883 18253720 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
22.86 | 6150874 17172636 2563599 18308698 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
propiconazole |
22.86 | 17178689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
triadimefon |
22.86 | 17178689 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.53 | 11989578 17391786 15350150 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
3.33 | 12587719 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
4.42 | 18516814 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.94 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
2.35 | 16809336 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.00 | 14737004 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
2.82 | 11408345 17203775 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.50 | 19513568 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
4.85 | 12754197 17974566 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.41 | 17484760 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.80 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.44 | 3581430 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.35 | 15738583 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.87 | 6679447 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.81 | 18514411 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.68 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
8.68 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.96 | 3988306 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.30 | 17016548 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.50 | 16525653 17393432 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.34 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.47 | 16965848 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.42 | 7296757 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.41 | 6228378 |
MESH:D020774 |
Pick Disease of the Brain |
marker/mechanism |
|
| |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.49 | 12224865 11605937 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.56 | 2563599 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.42 | 18760546 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.44 | 12752131 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
2.83 | 12832656 11597910 12490602 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.69 | 10835634 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.32 | 3692021 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.83 | 18045962 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.77 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
5.77 | 3137016 16876388 11442880 4039156 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.76 | 6407741 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
5.02 | 18724381 |
MESH:D012871 |
Skin Diseases |
|
monomethylarsonous acid |
3.36 | 17431481 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.22 | 15862959 16503802 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
2.32 | 12958204 17575124 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
3.26 | 18087811 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
4.22 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
4.13 | 19225199 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.10 | 15821434 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
4.70 | 19731979 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.80 | 1399818 6587162 7505956 6582329 3712494 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
11.80 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
triadimefon |
11.80 | 17178689 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.80 | 18020914 19584973 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
4.13 | 17467628 11989578 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.29 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
8.29 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
monomethylarsonous acid |
8.29 | 20375083 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.26 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.91 | 10982225 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
4.59 | 18645019 |